Guided Therapeutics (GTHP) Shares Outstanding (Diluted) (2015 - 2026)
Guided Therapeutics (GTHP) Shares Outstanding (Diluted) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 386.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 577.60 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 390.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 454.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 968.57 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 97.90 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 96.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 96.54 Mn |
| Dec 31, 2025 | 78.41 Mn |
| Sep 30, 2025 | 81.69 Mn |
| Jun 30, 2025 | 78.84 Mn |
| Mar 31, 2025 | 68.29 Mn |
| Dec 31, 2024 | 57.34 Mn |
| Sep 30, 2024 | 57.04 Mn |
| Jun 30, 2024 | 55.99 Mn |
| Mar 31, 2024 | 54,750.00 |
| Dec 31, 2023 | 51.13 Mn |
| Sep 30, 2023 | 51.47 Mn |
| Jun 30, 2023 | 50.97 Mn |
| Mar 31, 2023 | 49.30 Mn |
| Dec 31, 2022 | 32.51 Mn |
| Sep 30, 2022 | 34.83 Mn |
| Jun 30, 2022 | 26.34 Mn |
| Mar 31, 2022 | 20.68 Mn |
| Dec 31, 2021 | 13.38 Mn |
| Sep 30, 2021 | 13.42 Mn |
| Jun 30, 2021 | 13.28 Mn |